119 related articles for article (PubMed ID: 445402)
1. Potentiation of anticancer agent cytotoxicity against sensitive and resistant AKR leukemia by amphotericin B1.
Valeriote F; Medoff G; Dieckman J
Cancer Res; 1979 Jun; 39(6 Pt 1):2041-5. PubMed ID: 445402
[TBL] [Abstract][Full Text] [Related]
2. Potentiation of anticancer agents by amphotericin B.
Medoff G; Valeriote F; Dieckman J
J Natl Cancer Inst; 1981 Jul; 67(1):131-5. PubMed ID: 6942183
[TBL] [Abstract][Full Text] [Related]
3. [Studies and progress on the enhancement of therapeutic effects of antitumor drugs].
Tsukagoshi S
Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 2):1107-15. PubMed ID: 6408997
[TBL] [Abstract][Full Text] [Related]
4. Resistance and cross-resistance of cultured leukemia P388 cells to vincristine, adriamycin, adriamycin analogs, and actinomycin D.
Wilkoff LJ; Dulmadge EA
J Natl Cancer Inst; 1978 Dec; 61(6):1521-4. PubMed ID: 281559
[TBL] [Abstract][Full Text] [Related]
5. Inability of amphotericin B(Fungizone) or of sodium deoxycholate to alter natural drug resistance or sensitivity of transplanted murine leukemias.
Ganu UK; Khandalekar DD; Gokhale SV
Indian J Physiol Pharmacol; 1984; 28(1):21-6. PubMed ID: 6490126
[TBL] [Abstract][Full Text] [Related]
6. Decreased retention of actinomycin D as the basis for cross-resistance in anthracycline-resistant sublines of P388 leukemia.
Inaba M; Johnson RK
Cancer Res; 1977 Dec; 37(12):4629-34. PubMed ID: 922743
[TBL] [Abstract][Full Text] [Related]
7. Potentiation of cytotoxicity of anticancer agents by several different polyene antibiotics.
Valeriote F; Medoff G; Dieckman J
J Natl Cancer Inst; 1984 Feb; 72(2):435-9. PubMed ID: 6582328
[TBL] [Abstract][Full Text] [Related]
8. Synergistic effect of amphotericin B and 1,3-bis(2-chloroethyl)-1-nitrosourea against a transplantable AKR leukemia.
Medoff G; Valeriote F; Lynch RG; Schlessinger D; Kobayashi GS
Cancer Res; 1974 May; 34(5):974-8. PubMed ID: 4823906
[No Abstract] [Full Text] [Related]
9. Relationship between modulation of natural killer cell activity and antitumor activity of bropirimine when used in combination with various types of chemotherapeutic drugs.
Li LH; DeKoning TF; Wallace TL
Cancer Res; 1987 Nov; 47(22):5894-900. PubMed ID: 3664490
[TBL] [Abstract][Full Text] [Related]
10. Amphotericin B potentiation of the cytotoxicity of anticancer agents against both normal hematopoietic and leukemia cells in mice.
Valeriote F; Medoff G; Tolen S; Dieckman J
J Natl Cancer Inst; 1984 Aug; 73(2):475-82. PubMed ID: 6589439
[TBL] [Abstract][Full Text] [Related]
11. Effects of quinidine and related compounds on cytotoxicity and cellular accumulation of vincristine and adriamycin in drug-resistant tumor cells.
Tsuruo T; Iida H; Kitatani Y; Yokota K; Tsukagoshi S; Sakurai Y
Cancer Res; 1984 Oct; 44(10):4303-7. PubMed ID: 6467192
[TBL] [Abstract][Full Text] [Related]
12. Potentiation of vincristine and actinomycin D by a new synthetic imidazole anti-tumor agent YM534 active against human cancer cells and multidrug-resistant cells.
Sato S; Watanabe Y; Okamura K; Hamanaka R; Mori T; Kohno K; Kuwano M
Anticancer Drug Des; 1989 Aug; 4(2):125-35. PubMed ID: 2803461
[TBL] [Abstract][Full Text] [Related]
13. [Reversal of acquired resistance to vinca alkaloids and anthracycline antibiotics by calcium channel blockers and calmodulin inhibitors].
Tsuruo T
Gan To Kagaku Ryoho; 1984 Mar; 11(3 Pt 2):750-9. PubMed ID: 6585181
[TBL] [Abstract][Full Text] [Related]
14. Resistance to adriamycin: relationship of cytotoxicity to drug uptake and DNA single- and double-strand breakage in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia.
Goldenberg GJ; Wang H; Blair GW
Cancer Res; 1986 Jun; 46(6):2978-83. PubMed ID: 3698020
[TBL] [Abstract][Full Text] [Related]
15. Amphotericin B-induced sensitivity to actinomycin D in drug-resistant Hela cells.
Medoff J; Medoff G; Goldstein MN; Schlessinger D; Kobayaski GS
Cancer Res; 1975 Sep; 35(9):2548-52. PubMed ID: 1149049
[TBL] [Abstract][Full Text] [Related]
16. Reversal of resistance to vincristine in P388 leukemia by various polycyclic clinical drugs, with a special emphasis on quinacrine.
Inaba M; Maruyama E
Cancer Res; 1988 Apr; 48(8):2064-7. PubMed ID: 3349478
[TBL] [Abstract][Full Text] [Related]
17. In vivo enhancement of 5-fluorouracil cytotoxicity to AKR leukemia cells by thymidine in mice.
Santelli G; Valeriote F
J Natl Cancer Inst; 1978 Sep; 61(3):843-7. PubMed ID: 278862
[TBL] [Abstract][Full Text] [Related]
18. Schedule-dependent potentiation of lomustine cytotoxicity by amphotericin B in mice.
Valeriote F; Dieckman J; Chabot G
J Natl Cancer Inst; 1986 Mar; 76(3):521-5. PubMed ID: 3456466
[TBL] [Abstract][Full Text] [Related]
19. Circumvention of vincristine and Adriamycin resistance in vitro and in vivo by calcium influx blockers.
Tsuruo T; Iida H; Nojiri M; Tsukagoshi S; Sakurai Y
Cancer Res; 1983 Jun; 43(6):2905-10. PubMed ID: 6850602
[TBL] [Abstract][Full Text] [Related]
20. Protection and potentiation of nitrogen mustard cytotoxicity by WR-2721.
Valeriote F; Tolen S
Cancer Res; 1982 Nov; 42(11):4330-1. PubMed ID: 6290032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
